Christopher Rohde investigated the effects of clozapine in borderline personality disorder. Clozapine was associated with a reduction in psychiatric admissions from 2.52 (95%-CI 2.31-2.78) to 2.00 (95%-CI 1.77-2.23) admissions and a reduction in psychiatric bed-days from 190.08 (95%-CI 176.84-203.33) to 65.95 (95%-CI 58.27-73.66) bed-days. Further, the number of patients with intentional self-harm or overdose decreased significantly from 189 to 114 individuals after clozapine initiation. Read more here.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s